Interview with Dr. Aubrey de Grey, founder of SENS
Watch my fast-paced interview with Dr. Aubrey de Grey, Chief Science Officer of the SENS Research Foundation. SENS is the Strategies for Engineered Negligible Senescence.
Watch my fast-paced interview with Dr. Aubrey de Grey, Chief Science Officer of the SENS Research Foundation. SENS is the Strategies for Engineered Negligible Senescence.
In my search for wisdom about aging, I maintain that the primary cause is telomere shortening. This does not mean that methylation, signaling with stem cell produced vesicles (like packages with a purpose) don’t play a secondary role.
I would like to recommend the TV show, Younger for its new take on telling women’s stories. Let’s hear it for the women who bravely face the challenges of balancing reproductive capacity, career, freedom, and having to tolerate men.
A body is a machine in turn made up of trillions of cellular machines, all exhibiting decreasing genomic integrity and stability as we age. Here are some insights which help to explain aging as the result of increasing entropy
I have noted that over the last nine years, taking telomerase activators in my patients can lead to increases but that this does not result in continuous lengthening. Now, we understand why this is the case.
My friends, we may have reached an inflection point in human civilization due to trust in institutions and mistrust of humanity. In some ways, the signs of the times argue that humanity peaked around 2014 and is now in decline.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness